Global Health Limited Cash Flow Reinvestment Rate

Latest as of September 2025: 1.26x

Global Health Limited cash flow reinvestment rate. Global Health Limited (MEDANTA) has a Cash Flow Reinvestment Rate of 1.26x as of September 2025, reinvesting Rs4.13 Billion (capex Rs4.13 Billion ) from operating cash flow of Rs3.29 Billion. See financial agility of Global Health Limited to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

1.26x
(Capex + Investments) / Operating CF

Total Reinvested

Rs4.13 Billion
Capex + Investments

Operating Cash Flow

Rs3.29 Billion
INR

Capital Expenditures

Rs4.13 Billion
INR

Cash Flow Reinvestment Rate of Global Health Limited (2019–2026)

Cash flow reinvestment rate of Global Health Limited from 2019 to 2026. Historical reinvestment intensity for Global Health Limited across 8 annual periods. Explore debt repayment capacity of Global Health Limited to assess how comfortably operating cash covers total debt obligations.

Global Health Limited Cash Flow Reinvestment Rate by Year (2019–2026)

Global Health Limited cash flow reinvestment rate by year from 2019 to 2026. Year-by-year capital reinvestment analysis for Global Health Limited. For the full cash flow conversion analysis, see Global Health Limited (MEDANTA) cash flow conversion.

Year Reinvestment Rate Total Reinvested (INR) Operating CF Capex YoY Change
2026 1.55x Rs11.68 Billion Rs7.53 Billion Rs9.79 Billion ▼ -21.9%
2025 1.98x Rs12.37 Billion Rs6.24 Billion Rs5.17 Billion ▲ +68.8%
2024 1.18x Rs7.19 Billion Rs6.12 Billion Rs2.79 Billion ▲ +31.0%
2023 0.90x Rs5.78 Billion Rs6.45 Billion Rs2.36 Billion ▼ -59.8%
2022 2.23x Rs6.95 Billion Rs3.11 Billion Rs2.74 Billion ▲ +40.3%
2021 1.59x Rs3.85 Billion Rs2.42 Billion Rs1.46 Billion ▲ +1.2%
2020 1.57x Rs2.75 Billion Rs1.75 Billion Rs1.88 Billion ▼ -19.0%
2019 1.94x Rs3.00 Billion Rs1.54 Billion Rs3.00 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow